In this study, we tested one mIgA- and two IgAM-containing preparations and benchmarked them against IgG, which has been extensively tested in influenza infections.8 We developed a novel CD89 Tg mouse to allow the unbiased comparison of the four Ig preparations in controlling Cal7 and PR8 influenza infections in vivo. This evidence concerns the gene FCAR and influenza.